부산대학교 도서관

Kerr, Sarah E ; Schnabel, Catherine A ; Sullivan, Peggy S ; Zhang, Yi ; Huang, Vivian J ; Erlander, Mark G ; Brachtel, Elena F ; Dry, Sarah M

In Modern Pathology January 2014 27(1):44-54

Sgroi, Dennis C ; Sestak, Ivana ; Cuzick, Jack ; Zhang, Yi ; Schnabel, Catherine A ; Schroeder, Brock ; Erlander, Mark G ; Dunbier, Anita ; Sidhu, Kally ; Lopez-Knowles, Elena ; Goss, Paul E ; Dowsett, Mitch

In The Lancet Oncology October 2013 14(11):1067-1076

O'Regan RM; Department of Medicine, University of Rochester, Rochester, New York.; Ren Y; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Zhang Y; Biotheranostics, A Hologic Company, San Diego, California.; Siuliukina N; Biotheranostics, A Hologic Company, San Diego, California.; Schnabel CA; Biotheranostics, A Hologic Company, San Diego, California.; Kammler R; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Viale G; International Breast Cancer Study Group Central Pathology Office, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.; Dell'Orto P; International Breast Cancer Study Group Central Pathology Office, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.; Munzone E; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Láng I; Clinexpert-Research, Budapest, Hungary.; Tondini C; Ospedale Papa Giovanni XXIII, Bergamo, Italy.; Gomez HL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.; Chini C; Deaprment of Medical Oncology, Azienda Socio Sanitaria Territoriale dei Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.; Nicoletti SVL; Department of Medical Oncology, Ospedale Infermi Rimini, Ausl Romagna, Italy.; Puglisi F; Department of Medicine, University of Udine, Udine, Italy.; Department of Medical Oncology, National Cancer Institute, Centro di Riferimento Oncologico, IRCCS, Aviano, Pordenone, Italy.; Zaman K; Swiss Group for Clinical Cancer Research, Bern, Switzerland.; Department of Medical Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Goetz MP; Mayo Clinic Department of Oncology, and Alliance for Clinical Trials in Oncology, Rochester, Minnesota.; Stearns V; Meyer Cancer Center, Weill Cornell Medicine, New York.; Martino S; The Angeles Clinic and Research Institute, Santa Monica, California.; SWOG Cancer Research Network, San Antonio, Texas.; Salim M; Allan Blair Cancer Center, Regina, Saskatchewan, Canada.; Loibl S; German Breast Group Forschungs GmbH, Neu-Isenburg, Germany.; Goethe University, Frankfurt am Main, Germany.; Geyer CE; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania.; NSABP Foundation, NRG Oncology, Pittsburgh, Pennsylvania.; Bonnefoi HR; Institut Bergonié, Université de Bordeaux Collège Sciences de la santé, INSERM U1312, Bordeaux, France.; European Organization for Research and Treatment of Cancer, Brussels, Belgium.; Ciruelos EM; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain.; Loi S; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne Australia.; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Colleoni M; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy.; Fleming GF; The University of Chicago Medical Center, Chicago, Illinois.; Francis PA; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia.; St Vincent's Hospital, Melbourne, Australia.; Breast Cancer Trials Australia and New Zealand, Newcastle, Australia.; Walley BA; University of Calgary, Calgary, Alberta, Canada.; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.; Pagani O; Geneva University Hospitals, Geneva, Switzerland.; Lugano University, Lugano, Switzerland.; Swiss Group for Clinical Cancer Research, Bern, Switzerland.; Treuner K; Biotheranostics, A Hologic Company, San Diego, California.; Regan MM; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Schnabel, Catherine A ; Godin, Robert E ; Cleary, Michael L

In Developmental Biology 2003 254(2):262-276

Schnabel, Catherine A; Jacobs, Yakop; Cleary, Michael L

Oncogene. 2/3/2000, Vol. 19 Issue 5, p608. 9p.

Buus, Richard; Sestak, Ivana; Kronenwett, Ralf; Ferree, Sean; Schnabel, Catherine A; Baehner, Frederick L; Mallon, Elizabeth A; Cuzick, Jack; Dowsett, Mitch

Journal of Clinical Oncology. 1/10/2021, Vol. 39 Issue 2, p126-135. 10p.

Foldi J; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, 06510, USA. Foldij@upmc.edu.; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA. Foldij@upmc.edu.; Tsagianni A; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.; Salganik M; Biotheranostics Inc, A Hologic Company, San Diego, CA, 92121, USA.; Schnabel CA; Biotheranostics Inc, A Hologic Company, San Diego, CA, 92121, USA.; Brufsky A; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.; van Londen GJ; Division of Hematology and Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.; Pusztai L; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, 06510, USA.; Sanft T; Section of Medical Oncology, Yale School of Medicine, New Haven, CT, 06510, USA. Tara.sanft@yale.edu.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

O'Regan RM; University of Rochester Department of Medicine, Rochester, New York.; Zhang Y; Biotheranostics, A Hologic Company, San Diego, California.; Fleming GF; The University of Chicago Medical Center, Chicago, Illinois.; Francis PA; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia.; St Vincent's Hospital, Melbourne, Australia.; Breast Cancer Trials Australia & New Zealand, Newcastle, Australia.; University of Newcastle, Callaghan, Newcastle, Australia.; Kammler R; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Viale G; International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology IRCCS, Milan, Italy.; Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy.; Dell'Orto P; Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy.; Lang I; Clinexpert-Research, Budapest, Hungary.; Bellet M; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain.; Bonnefoi HR; Institut Bergonie Comprehensive Cancer Center, Universite de Bordeaux, INSERM U1312, Bordeaux, France.; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Tondini C; Ospedale Papa Giovanni XXIII, Bergamo, Italy.; Villa F; Oncology Unit, Department of Oncology, Alessandro Manzoni Hospital, ASST Lecco, Lecco, Italy.; Bernardo A; Operative Unit of Medical Oncology, IRCCS ICS Maugeri, Pavia, Italy.; Ciruelos EM; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain.; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.; Neven P; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Gynecologic Oncology and Multidisciplinary Breast Center, University Hospitals UZ Leuven, KU Leuven, Leuven, Belgium.; Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Müller B; Chilean Cooperative Group for Oncologic Research (GOCCHI), Santiago, Chile.; Jochum W; Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Zaman K; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Breast Center, Lausanne University Hospital CHUV, Lausanne, Switzerland.; Martino S; The Angeles Clinic and Research Institute, Santa Monica, California.; SWOG Cancer Research Network, San Antonio, Texas.; Geyer CE Jr; University of Pittsburgh Medical Center Hillman Cancer Center Pittsburgh, Pennsylvania.; NSABP Foundation/NRG Oncology, Pittsburgh, Pennsylvania.; Jerzak KJ; Division of Medical Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.; Davidson NE; Fred Hutchinson Cancer Center, University of Washington Seattle, Washington.; ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania.; Coleman RE; Weston Park Hospital, Sheffield, United Kingdom.; National Cancer Research Institute, Breast Cancer Clinical Studies Group (NCRI-BCSG), London, United Kingdom.; The Institute for Cancer Research, The Clinical Trials and Statistics Unit (ICR-CTSU), London, United Kingdom.; Ingle JN; Mayo Clinic and Alliance for Clinical Trials in Oncology, Rochester, Minnesota.; van Mackelenbergh MT; German Breast Group, Neu Isenburg, Germany.; University Hospital of Schleswig-Holstein, Campus Kiel, Germany.; Loi S; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne Australia.; Colleoni M; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Schnabel CA; Biotheranostics, A Hologic Company, San Diego, California.; Treuner K; Biotheranostics, A Hologic Company, San Diego, California.; Regan MM; IBCSG Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Fuentes Bayne HE; Mayo Clinic, Rochester, MN.; Kasi PM; Weill Cornell Medicine, New York, NY.; Ma L; Biotheranostics, a Hologic Company, San Diego, CA.; Hart LL; Florida Cancer Specialist, Fort Myers, FL.; Wong J; Biotheranostics, a Hologic Company, San Diego, CA.; Spigel DR; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Schnabel CA; Biotheranostics, a Hologic Company, San Diego, CA.; Reeves JA; Florida Cancer Specialist, Fort Myers, FL.; Halfdanarson TR; Mayo Clinic, Rochester, MN.; Treuner K; Biotheranostics, a Hologic Company, San Diego, CA.; Greco FA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Schnabel, Catherine A; Selleri, Licia; Jacobs, Yakop; Warnke, Roger; Cleary, Michael L

In Mechanisms of Development 2001 100(1):131-135

Mamounas EP; Orlando Health Cancer Institute, Orlando, Florida.; Bandos H; NRG Oncology SDMC, and the University of Pittsburgh, Pittsburgh, Pennsylvania.; Rastogi P; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Magee-Womens Hospital, Pittsburgh, Pennsylvania.; Zhang Y; Biotheranostics, Inc., A Hologic Company, San Diego, California.; Treuner K; Biotheranostics, Inc., A Hologic Company, San Diego, California.; Lucas PC; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Geyer CE Jr; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Fehrenbacher L; Kaiser Permanente Oncology Clinical Trials Northern CA, Novato, California.; Chia SK; British Columbia Cancer Agency, and the University of British Columbia, Vancouver, British Columbia, Canada.; Brufsky AM; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Magee-Womens Hospital, Pittsburgh, Pennsylvania.; Walshe JM; Cancer Trials Ireland (formerly known as Irish Clinical Oncology Research Group-ICORG), Dublin, Ireland.; Soori GS; Florida Cancer Specialists, Ft. Myers, Florida.; Dakhil S; CCOP Wichita/Cancer Center of Kansas, Wichita, Kansas.; Paik S; Theragenbio, Inc., Pankyo, Republic of South Korea, and Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of South Korea.; Swain SM; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.; Sgroi DC; Massachusetts General Hospital, Boston, Massachusetts.; Schnabel CA; Biotheranostics, Inc., A Hologic Company, San Diego, California.; Wolmark N; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Bartlett JMS; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, United Kingdom.; Xu K; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Wong J; Biotheranostics, A Hologic Company, San Diego, California.; Pond G; Department of Biostatistics, McMaster University, Hamilton, Ontario.; Zhang Y; Biotheranostics, A Hologic Company, San Diego, California.; Spears M; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario.; Salunga R; Biotheranostics, A Hologic Company, San Diego, California.; Mallon E; Department of Pathology, Glasgow, United Kingdom.; Taylor KJ; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, United Kingdom.; Hasenburg A; Department of Gynecology and Obstetrics, University Center Mainz, Mainz, Germany.; Markopoulos C; National and Kapodistrian University of Athens, Medical School, Athens, Greece.; Dirix L; St. Augustinus Hospital, Antwerp, Belgium.; van de Velde CJH; Leiden University Medical Center, Leiden, the Netherlands.; Rea D; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom.; Schnabel CA; Biotheranostics, A Hologic Company, San Diego, California.; Treuner K; Biotheranostics, A Hologic Company, San Diego, California.; Bayani J; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Heeke S; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gay CM; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Estecio MR; Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tran H; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Morris BB; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang B; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tang X; Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Raso MG; Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rocha P; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.; Lai S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UTHealth Houston, Houston, TX, USA.; Arriola E; Medical Oncology Department, Hospital del Mar, Barcelona, Spain.; Hofman P; Laboratory of Clinical and Experimental Pathology, IHU RespirERA, Nice Hospital, University Côte d'Azur, Nice, France.; Hofman V; Laboratory of Clinical and Experimental Pathology, IHU RespirERA, Nice Hospital, University Côte d'Azur, Nice, France.; Kopparapu P; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.; Lovly CM; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.; Concannon K; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; De Sousa LG; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lewis WE; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kondo K; Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hu X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tanimoto A; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Vokes NI; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nilsson MB; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Stewart A; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jansen M; Pulmonary Department, Ziekenhuisgroep Twente, Hengelo, the Netherlands.; Horváth I; National Korányi Institute of Pulmonology, Budapest, Hungary.; Gaga M; 7th Respiratory Medicine Department, Athens Chest Hospital, Athens, Greece.; Panagoulias V; 2nd Respiratory Medicine Department, Athens Chest Hospital, Athens, Greece.; Raviv Y; Department of Medicine, Pulmonology, Institute, Soroka Medical Center, Ben-Gurion University, Beer-Sheva, Israel.; Frumkin D; Nucleix Ltd. Rehovot, Israel.; Wasserstrom A; Nucleix Ltd. Rehovot, Israel.; Shuali A; Nucleix Ltd. Rehovot, Israel.; Schnabel CA; Nucleix Inc, San Diego, CA, USA.; Xi Y; Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Diao L; Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang Q; Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Van Loo P; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The Francis Crick Institute, London, UK.; Wang J; Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wistuba II; Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Byers LA; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: lbyers@mdanderson.org.; Heymach JV; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jheymach@mdanderson.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Raghav K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Overman M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Poage GM; Biotheranostics, Inc., San Diego, California, USA.; Soifer HS; Biotheranostics, Inc., San Diego, California, USA.; Schnabel CA; Biotheranostics, Inc., San Diego, California, USA.; Varadhachary GR; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Hainsworth, John D; Schnabel, Catherine A; Erlander, Mark G; Haines 3rd, David W; Greco, F Anthony

Clinical Colorectal Cancer; 2012 Jun, Vol. 11 Issue 2, p112-118, 7p

Bartlett, John MS; Xu, Keying; Wong, Jenna; Pond, Gregory Russell; Zhang, Yi; Spears, Melanie; Salunga, Ranelle C.; Mallon, Elizabeth; Taylor, Karen J; Hasenburg, Annette; Markopoulos, Christos; Dirix, Luc Yves; Seynaeve, Caroline M.; Van De Velde, Cornelis J.H.; Rea, Daniel William; Schnabel, Catherine A; Treuner, Kai; Bayani, Jane

Journal of Clinical Oncology. 2023 Supplement 16, Vol. 41, p509-509. 1p.

British Journal of Diabetes & Vascular Disease; Jul2005, Vol. 5 Issue 4, p227-235, 9p

Brachtel, Elena F; Operaña, Theresa N; Sullivan, Peggy S; Kerr, Sarah E; Cherkis, Karen A; Schroeder, Brock E; Dry, Sarah M; Schnabel, Catherine A

Oncotarget
Oncotarget, vol 7, iss 19

Sgroi DC; Molecular Pathology Research Unit, Department of Pathology, Harvard Medical School, Massachusetts General Hospital East, 149 13th Street, Charlestown, MA, 02129, USA. dsgroi@mgh.harvard.edu.; Massachusetts General Hospital Center for Cancer Research, Harvard Medical School, Boston, MA, USA. dsgroi@mgh.harvard.edu.; Treuner K; Biotheranostics, A Hologic Company, San Diego, CA, USA.; Zhang Y; Biotheranostics, A Hologic Company, San Diego, CA, USA.; Piper T; University of Edinburgh, Edinburgh, UK.; Salunga R; Biotheranostics, A Hologic Company, San Diego, CA, USA.; Ahmed I; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.; Doos L; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.; Thornber S; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.; Taylor KJ; University of Edinburgh, Edinburgh, UK.; Brachtel E; Molecular Pathology Research Unit, Department of Pathology, Harvard Medical School, Massachusetts General Hospital East, 149 13th Street, Charlestown, MA, 02129, USA.; Massachusetts General Hospital Center for Cancer Research, Harvard Medical School, Boston, MA, USA.; Pirrie S; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.; Schnabel CA; Biotheranostics, A Hologic Company, San Diego, CA, USA.; Rea D; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.; Bartlett JMS; University of Edinburgh, Edinburgh, UK.; Ontario Institute for Cancer Research, Ontario, Toronto, ON, Canada.; University of Toronto, Toronto, ON, Canada.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Jerevall PL; Molecular Pathology Unit, Massachusetts General Hospital, 149 13th Street, Charlestown, MA, 02129, USA.; Center for Cancer Research, Massachusetts General Hospital, 149 13th Street, Charlestown, MA, 02129, USA.; Department of Pathology, Harvard Medical School, Boston, MA, 02115, USA.; Brock J; Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.; Palazzo J; Jefferson Medical Center, 132 South 10th Street, Philadelphia, PA, 19107, USA.; Wieczorek T; Brigham and Women's Faulkner Hospital, 1153 Centre Street, Boston, MA, 02130, USA.; Misialek M; Department of Pathology, Newton-Wellesley Hospital, 2014 Washington Street, Newton, MA, 02462, USA.; Guidi AJ; North Shore Medical Center, 81 Highland Ave, Salem, MA, 01970, USA.; Wu Y; Department of Pathology/Laboratory Medicine, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.; Erlander MG; Trovagene, Inc, 11055 Flintkote Avenue, San Diego, CA, 92121, USA.; Zhang Y; Biotheranostics, 9640 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA.; Schnabel CA; Biotheranostics, 9640 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA.; Goss PE; Center for Cancer Research, Massachusetts General Hospital, 149 13th Street, Charlestown, MA, 02129, USA.; Horick N; Biostatistics Center, Massachusetts General Hospital, 32 Fruit Street, Boston, MA, 02114, USA.; Sgroi DC; Molecular Pathology Unit, Massachusetts General Hospital, 149 13th Street, Charlestown, MA, 02129, USA. dsgroi@mgh.harvard.edu.; Center for Cancer Research, Massachusetts General Hospital, 149 13th Street, Charlestown, MA, 02129, USA. dsgroi@mgh.harvard.edu.; Department of Pathology, Harvard Medical School, Boston, MA, 02115, USA. dsgroi@mgh.harvard.edu.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE